http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9814458-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ae61ec15d33b0668344c8131e6b4462 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-06 |
| filingDate | 1997-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58c474d9b2b7a16f8d0baeb06d5f0916 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a38766222cbe34c13ba5ca123b1549e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70027bd5f4505c14a1a8da69feac6804 |
| publicationDate | 1998-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9814458-A1 |
| titleOfInvention | Antiinflammatory cell adhesion inhibitors |
| abstract | The invention relates to novel mimetics of oligosaccharides, preferably of derivatives of sialyl-LewisX (sLeX) and sialyl-LewisA (sLeA), with improved action as inhibitors of cell adhesion, a process for the preparation of these compounds, and their use as pharmacological active compounds and as diagnostics, and pharmaceuticals which contain these compounds. They are represented by formulae (Ix) (Ia), wherein R1 is a lipophilic radical or a sugar residue. |
| priorityDate | 1996-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.